Methamphetamine inhibits HIV-1 replication in CD4+ T cells by modulating Anti-HIV-1 miRNA expression

American Journal of Pathology

Volumn 184, Issue 1, 2014, Pages 92-100

  Mantri, Chinmay K ^a   Mantri, Jyoti V ^a   Pandhare, Jui ^a   Dash, Chandravanu ^a,b,c  

^a Vanderbilt Meharry Center for AIDS Research ^*  (United States)

^b MEHARRY MEDICAL COLLEGE   (United States)

^c VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

METHAMPHETAMINE; MICRORNA; MICRORNA 125B; MICRORNA 150; MICRORNA 28 5P; SMALL UNTRANSLATED RNA; UNCLASSIFIED DRUG;

ANTIVIRAL ACTIVITY; APOPTOSIS; ARTICLE; CD4+ T LYMPHOCYTE; CONTROLLED STUDY; CYTOTOXICITY; DRUG EFFECT; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; PATHOGENESIS; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION; RECEPTOR UPREGULATION; VIRUS INHIBITION; VIRUS LOAD; VIRUS REPLICATION; VIRUS STRAIN;

ADRENERGIC AGENTS; CD4-POSITIVE T-LYMPHOCYTES; CELL LINE; DOSE-RESPONSE RELATIONSHIP, DRUG; GENE EXPRESSION REGULATION; HIV-1; HUMANS; METHAMPHETAMINE; MICRORNAS; RNA, MESSENGER; VIRUS REPLICATION;

EID: 84890319517     PISSN: 00029440     EISSN: 15252191     Source Type: Journal    
DOI: 10.1016/j.ajpath.2013.09.011     Document Type: Article

References (58)

1. A.M. Kipp, A.J. Desruisseau, and H.Z. Qian Non-injection drug use and HIV disease progression in the era of combination antiretroviral therapy J Subst Abuse Treat 40 2011 386 396
2. H. Friedman, S. Pross, and T.W. Klein Addictive drugs and their relationship with infectious diseases FEMS Immunol Med Microbiol 47 2006 330 342
3. J.H. Khalsa, and W. Royal Do drugs of abuse impact on HIV disease? J Neuroimmunol 147 2004 6 8
4. G.A. Cabral Drugs of abuse, immune modulation, and AIDS J Neuroimmune Pharmacol 1 2006 280 295
5. M.K. Baum, C. Rafie, S. Lai, S. Sales, B. Page, and A. Campa Crack-cocaine use accelerates HIV disease progression in a cohort of HIV-positive drug users J Acquir Immune Defic Syndr 50 2009 93 99
6. J.A. Cook, J.K. Burke-Miller, M.H. Cohen, R.L. Cook, D. Vlahov, T.E. Wilson, E.T. Golub, R.M. Schwartz, A.A. Howard, C. Ponath, M.W. Plankey, A. Levine, and D.D. Grey Crack cocaine, disease progression, and mortality in a multicenter cohort of HIV-1 positive women AIDS 22 2008 1355 1363
7. J. Cofrancesco Jr., R. Scherzer, P.C. Tien, C.L. Gibert, H. Southwell, S. Sidney, A. Dobs, and C. Grunfeld Illicit drug use and HIV treatment outcomes in a US cohort AIDS 22 2008 357 365
8. H.Z. Qian, S.E. Stinnette, P.F. Rebeiro, A.M. Kipp, B.E. Shepherd, C.P. Samenow, C.A. Jenkins, P. No, C.C. McGowan, T. Hulgan, and T.R. Sterling The relationship between injection and noninjection drug use and HIV disease progression J Subst Abuse Treat 41 2011 14 20
9. T.E. Freese, J. Obert, A. Dickow, J. Cohen, and R.H. Lord Methamphetamine abuse: issues for special populations J Psychoactive Drugs 32 2000 177 182
10. S. Shoptaw, C.J. Reback, and T.E. Freese Patient characteristics, HIV serostatus, and risk behaviors among gay and bisexual males seeking treatment for methamphetamine abuse and dependence in Los Angeles J Addict Dis 21 2002 91 105
11. R.J. Ellis, M.E. Childers, M. Cherner, D. Lazzaretto, S. Letendre, and I. Grant Increased human immunodeficiency virus loads in active methamphetamine users are explained by reduced effectiveness of antiretroviral therapy J Infect Dis 188 2003 1820 1826
12. D.M. Smith, J.K. Wong, G.K. Hightower, C.C. Ignacio, K.K. Koelsch, C.J. Petropoulos, D.D. Richman, and S.J. Little HIV drug resistance acquired through superinfection AIDS 19 2005 1251 1256
13. G.N. Colfax, E. Vittinghoff, R. Grant, P. Lum, G. Spotts, and F.M. Hecht Frequent methamphetamine use is associated with primary non-nucleoside reverse transcriptase inhibitor resistance AIDS 21 2007 239 241
14. R.D. Moore, J.C. Keruly, and R.E. Chaisson Differences in HIV disease progression by injecting drug use in HIV-infected persons in care J Acquir Immune Defic Syndr 35 2004 46 51
15. M.P. Nair, Z.M. Saiyed, N. Nair, N.H. Gandhi, J.W. Rodriguez, N. Boukli, E. Provencio-Vasquez, R.M. Malow, and M.J. Miguez-Burbano Methamphetamine enhances HIV-1 infectivity in monocyte derived dendritic cells J Neuroimmune Pharmacol 4 2009 129 139
16. H. Liang, X. Wang, H. Chen, L. Song, L. Ye, S.H. Wang, Y.J. Wang, L. Zhou, and W.Z. Ho Methamphetamine enhances HIV infection of macrophages Am J Pathol 172 2008 1617 1624
17. E.S. Wires, D. Alvarez, C. Dobrowolski, Y. Wang, M. Morales, J. Karn, and B.K. Harvey Methamphetamine activates nuclear factor kappa-light-chain-enhancer of activated B cells (NF-kappaB) and induces human immunodeficiency virus (HIV) transcription in human microglial cells J Neurovirol 18 2012 400 410
18. S.S. Toussi, A. Joseph, J.H. Zheng, M. Dutta, L. Santambrogio, and H. Goldstein Short communication: methamphetamine treatment increases in vitro and in vivo HIV replication AIDS Res Hum Retroviruses 25 2009 1117 1121
19. H.C. Lane Pathogenesis of HIV infection: total CD4+ T-cell pool, immune activation, and inflammation Top HIV Med 18 2010 2 6
20. C.K. Mantri, J. Dash-Pandhare, J. Mantri, and C. Dash Cocaine enhances HIV-1 replication in CD4+ T cells by down-regulating miR-125b PLoS One 7 2012 e51387
21. Z. Talloczy, J. Martinez, D. Joset, Y. Ray, A. Gacser, S. Toussi, N. Mizushima, J.D. Nosanchuk, H. Goldstein, J. Loike, D. Sulzer, and L. Santambrogio Methamphetamine inhibits antigen processing, presentation, and phagocytosis PLoS Pathog 4 2008 e28
22. G.J. Riviere, W.B. Gentry, and S.M. Owens Disposition of methamphetamine and its metabolite amphetamine in brain and other tissues in rats after intravenous administration J Pharmacol Exp Ther 292 2000 1042 1047
23. B. Schweighardt, A.M. Roy, D.A. Meiklejohn, E.J. Grace 2nd, W.J. Moretto, J.J. Heymann, and D.F. Nixon R5 human immunodeficiency virus type 1 (HIV-1) replicates more efficiently in primary CD4+ T-cell cultures than X4 HIV-1 J Virol 78 2004 9164 9173
24. X. Wang, L. Ye, Y. Zhou, M.Q. Liu, D.J. Zhou, and W.Z. Ho Inhibition of anti-HIV microRNA expression: a mechanism for opioid-mediated enhancement of HIV infection of monocytes Am J Pathol 178 2011 41 47
25. J. Huang, F. Wang, E. Argyris, K. Chen, Z. Liang, H. Tian, W. Huang, K. Squires, G. Verlinghieri, and H. Zhang Cellular microRNAs contribute to HIV-1 latency in resting primary CD4+ T lymphocytes Nat Med 13 2007 1241 1247
26. B.C. Reiner, J.P. Keblesh, and H. Xiong Methamphetamine abuse, HIV infection, and neurotoxicity Int J Physiol Pathophysiol Pharmacol 1 2009 162 179
27. G. Colfax, and S. Shoptaw The methamphetamine epidemic: implications for HIV prevention and treatment Curr HIV/AIDS Rep 2 2005 194 199
28. R.A. Rawson, M.D. Anglin, and W. Ling Will the methamphetamine problem go away? J Addict Dis 21 2002 5 19
29. D.W. Purcell, S. Moss, R.H. Remien, W.J. Woods, and J.T. Parsons Illicit substance use, sexual risk, and HIV-positive gay and bisexual men: differences by serostatus of casual partners AIDS 19 Suppl 1 2005 S37 S47
30. P.N. Halkitis, J.T. Parsons, and M.J. Stirratt A double epidemic: crystal methamphetamine drug use in relation to HIV transmission among gay men J Homosex 41 2001 17 35
31. S.J. Semple, T.L. Patterson, and I. Grant Motivations associated with methamphetamine use among HIV+ men who have sex with men J Subst Abuse Treat 22 2002 149 156
32. L.N. Drumright, S.J. Little, S.A. Strathdee, D.J. Slymen, M.R. Araneta, V.L. Malcarne, E.S. Daar, and P.M. Gorbach Unprotected anal intercourse and substance use among men who have sex with men with recent HIV infection J Acquir Immune Defic Syndr 43 2006 344 350
33. J.A. Peck, C.J. Reback, X. Yang, E. Rotheram-Fuller, and S. Shoptaw Sustained reductions in drug use and depression symptoms from treatment for drug abuse in methamphetamine-dependent gay and bisexual men J Urban Health 82 2005 i100 i108
34. M.W. Plankey, D.G. Ostrow, R. Stall, C. Cox, X. Li, J.A. Peck, and L.P. Jacobson The relationship between methamphetamine and popper use and risk of HIV seroconversion in the multicenter AIDS cohort study J Acquir Immune Defic Syndr 45 2007 85 92
35. S. Shoptaw, and C.J. Reback Associations between methamphetamine use and HIV among men who have sex with men: a model for guiding public policy J Urban Health 83 2006 1151 1157
36. S. Shoptaw, and C.J. Reback Methamphetamine use and infectious disease-related behaviors in men who have sex with men: implications for interventions Addiction 102 Suppl 1 2007 130 135
37. A.R. Wohl, D.F. Johnson, S. Lu, W. Jordan, G. Beall, J. Currier, and P.A. Simon HIV risk behaviors among African American men in Los Angeles County who self-identify as heterosexual J Acquir Immune Defic Syndr 31 2002 354 360
38. T.L. Patterson, S.J. Semple, H. Staines, R. Lozada, P. Orozovich, J. Bucardo, M.M. Philbin, M. Pu, M. Fraga, H. Amaro, L. Torre Ade, G. Martinez, C. Magis-Rodriguez, and S.A. Strathdee Prevalence and correlates of HIV infection among female sex workers in 2 Mexico-US border cities J Infect Dis 197 2008 728 732
39. M.C. Marcondes, C. Flynn, D.D. Watry, M. Zandonatti, and H.S. Fox Methamphetamine increases brain viral load and activates natural killer cells in simian immunodeficiency virus-infected monkeys Am J Pathol 177 2010 355 361
40. M.A. Gavrilin, L.E. Mathes, and M. Podell Methamphetamine enhances cell-associated feline immunodeficiency virus replication in astrocytes J Neurovirol 8 2002 240 249
41. J. Sun, T. Soos, V.N. Kewalramani, K. Osiecki, J.H. Zheng, L. Falkin, L. Santambrogio, D.R. Littman, and H. Goldstein CD4-specific transgenic expression of human cyclin T1 markedly increases human immunodeficiency virus type 1 (HIV-1) production by CD4+ T lymphocytes and myeloid cells in mice transgenic for a provirus encoding a monocyte-tropic HIV-1 isolate J Virol 80 2006 1850 1862
42. J.C. Grivel, R.J. Shattock, and L.B. Margolis Selective transmission of R5 HIV-1 variants: where is the gatekeeper? J Transl Med 9 Suppl 1 2011 S6
43. M.P. Nair, S. Mahajan, D. Sykes, M.V. Bapardekar, and J.L. Reynolds Methamphetamine modulates DC-SIGN expression by mature dendritic cells J Neuroimmune Pharmacol 1 2006 296 304
44. M.P. Nair, and Z.M. Saiyed Effect of methamphetamine on expression of HIV coreceptors and CC-chemokines by dendritic cells Life Sci 88 2011 987 994
45. S.D. Mahajan, Z. Hu, J.L. Reynolds, R. Aalinkeel, S.A. Schwartz, and M.P. Nair Methamphetamine modulates gene expression patterns in monocyte derived mature dendritic cells: implications for HIV-1 pathogenesis Mol Diagn Ther 10 2006 257 269
46. R. Potula, and Y. Persidsky Adding fuel to the fire: methamphetamine enhances HIV infection Am J Pathol 172 2008 1467 1470
47. R. Harms, B. Morsey, C.W. Boyer, H.S. Fox, and N. Sarvetnick Methamphetamine administration targets multiple immune subsets and induces phenotypic alterations suggestive of immunosuppression PLoS One 7 2012 e49897
48. J.L. Cadet, I.N. Krasnova, S. Jayanthi, and J. Lyles Neurotoxicity of substituted amphetamines: molecular and cellular mechanisms Neurotox Res 11 2007 183 202
49. R. Saba, P.H. Storchel, A. Aksoy-Aksel, F. Kepura, G. Lippi, T.D. Plant, and G.M. Schratt Dopamine-regulated microRNA MiR-181a controls GluA2 surface expression in hippocampal neurons Mol Cell Biol 32 2012 619 632
50. D. Yang, T. Li, Y. Wang, Y. Tang, H. Cui, Y. Tang, X. Zhang, D. Chen, N. Shen, and W. Le miR-132 regulates the differentiation of dopamine neurons by directly targeting Nurr1 expression J Cell Sci 125 2012 1673 1682
51. C. Sarkar, D. Chakroborty, and S. Basu Neurotransmitters as regulators of tumor angiogenesis and immunity: the role of catecholamines J Neuroimmune Pharmacol 8 2013 7 14
52. Y. Zhang, L.X. Yan, Q.N. Wu, Z.M. Du, J. Chen, D.Z. Liao, M.Y. Huang, J.H. Hou, Q.L. Wu, M.S. Zeng, W.L. Huang, Y.X. Zeng, and J.Y. Shao miR-125b is methylated and functions as a tumor suppressor by regulating the ETS1 proto-oncogene in human invasive breast cancer Cancer Res 71 2011 3552 3562
53. Y. Numachi, H. Shen, S. Yoshida, K. Fujiyama, S. Toda, H. Matsuoka, I. Sora, and M. Sato Methamphetamine alters expression of DNA methyltransferase 1 mRNA in rat brain Neurosci Lett 414 2007 213 217
54. J.H. Arnsten, P.A. Demas, R.W. Grant, M.N. Gourevitch, H. Farzadegan, A.A. Howard, and E.E. Schoenbaum Impact of active drug use on antiretroviral therapy adherence and viral suppression in HIV-infected drug users J Gen Intern Med 17 2002 377 381
55. Qian HZ, McGowan CC, Mitchell VJ, Cassell H, Perez G, Bebawy S, Stinnette SE, Hulgan T, Sterling TR: Non-injection substance abuse, depression, and adherence to antiretroviral therapy among HIV-infected patients. 6th IAS Conference on HIV Pathogenesis, Treatment and Prevention, 17-20 July 2011, Rome, Italy, Abstract TUPE220
56. J.T. Parsons, W.J. Kowalczyk, M. Botsko, J. Tomassilli, and S.A. Golub Aggregate versus day level association between methamphetamine use and HIV medication non-adherence among gay and bisexual men AIDS Behav 17 2013 1478 1487
57. C. Marquez, S.J. Mitchell, C.B. Hare, M. John, and J.D. Klausner Methamphetamine use, sexual activity, patient-provider communication, and medication adherence among HIV-infected patients in care, San Francisco 2004-2006 AIDS are 21 2009 575 582
58. C.J. Reback, S. Larkins, and S. Shoptaw Methamphetamine abuse as a barrier to HIV medication adherence among gay and bisexual men AIDS care 15 2003 775 785